Adolfo López de Munaín

16.0k total citations · 1 hit paper
218 papers, 6.1k citations indexed

About

Adolfo López de Munaín is a scholar working on Molecular Biology, Neurology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Adolfo López de Munaín has authored 218 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 118 papers in Molecular Biology, 83 papers in Neurology and 73 papers in Cellular and Molecular Neuroscience. Recurrent topics in Adolfo López de Munaín's work include Parkinson's Disease Mechanisms and Treatments (59 papers), Genetic Neurodegenerative Diseases (53 papers) and Muscle Physiology and Disorders (41 papers). Adolfo López de Munaín is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (59 papers), Genetic Neurodegenerative Diseases (53 papers) and Muscle Physiology and Disorders (41 papers). Adolfo López de Munaín collaborates with scholars based in Spain, United States and France. Adolfo López de Munaín's co-authors include J.F. Martí-Massó, David Otaegui, Amets Sáenz, Itziar Abete, Ana Gorostidi, Ana Aiastui, Javier Ruiz‐Martínez, Ana Vieira, Teresa Norat and Dora Romaguera and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Neuroscience.

In The Last Decade

Adolfo López de Munaín

212 papers receiving 6.0k citations

Hit Papers

Association between total, processed, red and white meat ... 2014 2026 2018 2022 2014 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Adolfo López de Munaín Spain 42 3.1k 1.9k 1.6k 920 720 218 6.1k
Kun Xia China 41 3.8k 1.2× 1.2k 0.6× 1.6k 1.0× 672 0.7× 822 1.1× 403 7.0k
Tetsumori Yamashima Japan 47 2.6k 0.8× 1.3k 0.7× 1.4k 0.9× 867 0.9× 803 1.1× 206 7.1k
Masanori Nakagawa Japan 48 3.0k 1.0× 2.4k 1.2× 1.7k 1.1× 1.3k 1.4× 908 1.3× 324 8.3k
Avi Orr‐Urtreger Israel 47 4.7k 1.5× 1.9k 1.0× 1.5k 0.9× 1.4k 1.6× 835 1.2× 194 8.6k
Felipe A. Court Chile 42 3.2k 1.0× 1.1k 0.6× 2.4k 1.5× 882 1.0× 599 0.8× 88 6.3k
Joan X. Comella Spain 47 3.3k 1.1× 656 0.3× 1.7k 1.1× 623 0.7× 451 0.6× 112 5.7k
Paul R. Heath United Kingdom 48 3.3k 1.1× 2.5k 1.3× 972 0.6× 1.3k 1.4× 1.3k 1.8× 131 6.7k
Tatsushi Toda Japan 49 5.9k 1.9× 2.3k 1.2× 2.4k 1.6× 1.3k 1.4× 684 0.9× 339 9.6k
Barry W. Festoff United States 45 2.7k 0.9× 1.3k 0.7× 1.6k 1.0× 908 1.0× 699 1.0× 158 6.6k
Hidemi Misawa Japan 41 3.3k 1.1× 1.6k 0.8× 1.6k 1.0× 634 0.7× 1.3k 1.8× 114 5.7k

Countries citing papers authored by Adolfo López de Munaín

Since Specialization
Citations

This map shows the geographic impact of Adolfo López de Munaín's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adolfo López de Munaín with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adolfo López de Munaín more than expected).

Fields of papers citing papers by Adolfo López de Munaín

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Adolfo López de Munaín. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adolfo López de Munaín. The network helps show where Adolfo López de Munaín may publish in the future.

Co-authorship network of co-authors of Adolfo López de Munaín

This figure shows the co-authorship network connecting the top 25 collaborators of Adolfo López de Munaín. A scholar is included among the top collaborators of Adolfo López de Munaín based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Adolfo López de Munaín. Adolfo López de Munaín is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Villa, Pedro de la, José I. Miranda, J. M. Aizpurua, et al.. (2025). Topical Administration of Novel FKBP12 Ligand MP-004 Improves Retinal Function and Structure in Retinitis Pigmentosa Models. Investigative Ophthalmology & Visual Science. 66(3). 56–56.
2.
Villanúa, Jorge, et al.. (2025). Hyperconnectivity in resting-state fMRI as a marker of disease severity in Myotonic Dystrophy Type 1. Journal of Neuromuscular Diseases. 12(1). 90–101. 1 indexed citations
3.
Mirra, Serena, Yasmina Manso, Jaume del Valle, et al.. (2024). A mammalian-specific Alex3/Gα q protein complex regulates mitochondrial trafficking, dendritic complexity, and neuronal survival. Science Signaling. 17(822). eabq1007–eabq1007. 4 indexed citations
4.
Riva, Patricia de la, et al.. (2024). Understanding Endothelial Dysfunction and Its Role in Ischemic Stroke After the Outbreak of Recanalization Therapies. International Journal of Molecular Sciences. 25(21). 11631–11631. 4 indexed citations
5.
Cerro-Herreros, Estefanía, Juan J. Vílchez, Adolfo López de Munaín, et al.. (2024). AntimiR treatment corrects myotonic dystrophy primary cell defects across several CTG repeat expansions with a dual mechanism of action. Science Advances. 10(41). eadn6525–eadn6525. 1 indexed citations
6.
Yakhine-Diop, Sokhna M. S., José Á. Morales-García, Mireia Niso‐Santano, et al.. (2023). Changes in Liver Lipidomic Profile in G2019S-LRRK2 Mouse Model of Parkinson’s Disease. Cells. 12(5). 806–806. 2 indexed citations
7.
Aliri, Jone, et al.. (2022). A validated WAIS-IV short-form to estimate intellectual functioning in myotonic dystrophy type 1. Neuromuscular Disorders. 32(9). 749–753. 3 indexed citations
8.
García-Puga, Mikel, Ander Saenz‐Antoñanzas, Ander Matheu, & Adolfo López de Munaín. (2022). Targeting Myotonic Dystrophy Type 1 with Metformin. International Journal of Molecular Sciences. 23(5). 2901–2901. 14 indexed citations
9.
Uribe-Carretero, Elisabet, André R. A. Marques, Mafalda Lopes‐da‐Silva, et al.. (2022). Delay of EGF-Stimulated EGFR Degradation in Myotonic Dystrophy Type 1 (DM1). Cells. 11(19). 3018–3018. 3 indexed citations
10.
García-Puga, Mikel, Ander Saenz‐Antoñanzas, Gorka Gereñu, et al.. (2022). Senescence plays a role in myotonic dystrophy type 1. JCI Insight. 7(19). 13 indexed citations
11.
Palomo, Valle, et al.. (2021). Allosteric Modulation of GSK-3β as a New Therapeutic Approach in Limb Girdle Muscular Dystrophy R1 Calpain 3-Related. International Journal of Molecular Sciences. 22(14). 7367–7367. 7 indexed citations
12.
Díez, Ibai, Andone Sistiaga, María Cristina Caballero, et al.. (2021). Transcriptional signatures of synaptic vesicle genes define myotonic dystrophy type I neurodegeneration. Neuropathology and Applied Neurobiology. 47(7). 1092–1108. 12 indexed citations
13.
Yakhine-Diop, Sokhna M. S., Mario Rodríguez‐Arribas, Guadalupe Martínez-Chacón, et al.. (2021). The parkinsonian LRRK2 R1441G mutation shows macroautophagy-mitophagy dysregulation concomitant with endoplasmic reticulum stress. Cell Biology and Toxicology. 38(5). 889–911. 11 indexed citations
14.
Aizpurua, J. M., José I. Miranda, Aitziber Irastorza, et al.. (2021). Discovery of a novel family of FKBP12 “reshapers” and their use as calcium modulators in skeletal muscle under nitro-oxidative stress. European Journal of Medicinal Chemistry. 213. 113160–113160. 6 indexed citations
15.
Muñoz, J., Pablo Iruzubieta, Gorka Fernández‐Eulate, et al.. (2020). COL4A1 Mutation as a Cause of Familial Recurrent Intracerebral Hemorrhage. Journal of Stroke and Cerebrovascular Diseases. 29(4). 104652–104652. 6 indexed citations
16.
Fernández, Esther, Jorge Villanúa, Miren Zulaica, et al.. (2020). Neurodegeneration trajectory in pediatric and adult/late DM1: A follow‐up MRI study across a decade. Annals of Clinical and Translational Neurology. 7(10). 1802–1815. 15 indexed citations
17.
Díez, Ibai, Jorge Sepulcre, Esther Fernández, et al.. (2019). Regional brain atrophy in gray and white matter is associated with cognitive impairment in Myotonic Dystrophy type 1. NeuroImage Clinical. 24. 102078–102078. 23 indexed citations
18.
Aliri, Jone, et al.. (2019). Age‐related cognitive decline in myotonic dystrophy type 1: An 11‐year longitudinal follow‐up study. Journal of Neuropsychology. 14(1). 121–134. 18 indexed citations
19.
Padín, Juan Fernando, María Goicoechea, Ana Aiastui, et al.. (2013). Murine Muscle Engineered from Dermal Precursors: An In Vitro Model for Skeletal Muscle Generation, Degeneration, and Fatty Infiltration. Tissue Engineering Part C Methods. 20(1). 28–41. 9 indexed citations
20.
Bergareche, Alberto, E. De la Puente, Adolfo López de Munaín, et al.. (2001). Prevalence of Essential Tremor: A Door-to-Door Survey in Bidasoa, Spain. Neuroepidemiology. 20(2). 125–128. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026